Adaptive Biotechnologies Corp expected to post a loss of 34 cents a share - Earnings Preview

Adaptive Biotechnologies

04/05/2024 03:32

* Adaptive Biotechnologies Corp  ADPT.OQ   ADPT.O  is
expected
to show a rise in quarterly revenue when it reports  results on
May 7 for the period ending March 31 2024
    * The Seattle Washington-based  company is expected to
report a
3.0% increase in revenue to $38.784 million from $37.65 million
a year ago, according to the mean estimate from 7 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Adaptive Biotechnologies
Corp
is for a loss of 34 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 10.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $5.00​, above​ its last closing price
of $3.01. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.33       -0.33      -0.30     Beat    9.4
 Sep. 30 2023  -0.35       -0.34      -0.35     Missed  -3.3
 Jun. 30 2023  -0.35       -0.35      -0.33     Beat    4.8​
 Mar. 31 2023  -0.37       -0.38      -0.40     Missed  -6.2
 ​​Dec.        -0.34       -0.35      -0.28     Beat    19.2
 31 2022                                                
 Sep. 30 2022  -0.37       -0.38      -0.32     Beat    14.9​
 Jun. 30 2022  -0.41       -0.43      -0.37     Beat    14
 Mar. 31 2022  -0.45       -0.46      -0.44     Beat    4.1
 This summary was machine generated May 4 at 02:32 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)